Randomized Trial of Follow-up Strategies in Breast Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to determine whether family physician 'routine follow-up care' of women with breast cancer in remission is an acceptable alternative to the existing system of specialist follow-up. Primary outcome measure are event rates of oncological catastrophes and quality of life.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Women with breast cancer on well follow-up at regional cancer centres in Ontario and Manitoba
Diagnosed at least 12 months previously (range 9-15 months)
Without evidence of active disease (i.e., stages IIIB and IV excluded)
Free from any primary treatment complications
Primary treatment at least 3 months previously, except for continued use of tamoxifen
Still experiencing complications of primary treatment (patients will become eligible once complications resolve provided they are within the 6 month window)
Unable to identify an acceptable family physician to provide follow-up
Language or literacy skills inconsistent with completing questionnaires
Unable to comply with study protocol including completion of questionnaires
Previously enrolled in a study which requires continued follow-up in specialist or peripheral clinics
Actively followed at a cancer centre for another primary cancer